Clinical Trials Logo

Clinical Trial Summary

Non-invasive measurement of hemoglobin in infants and neonates scheduled for elective congenital heart surgery, weighing between 3kg and 20 kg. SpHb measurement will be compared to the gold standard of hemoglobin measurement - CO-oximetrie - and to the point-of-care (GEM 3500 premiere).


Clinical Trial Description

Non-invasive measurement of hemoglobin in infants and neonates scheduled for elective congenital heart surgery, weighing between 3kg and 20 kg. SpHb measurement will be compared to the gold standard of hemoglobin measurement - CO-oximetrie - and to the point-of-care (GEM 3500 premiere). Data collection whenever an arterial blood gas analysis is indicated by the experienced attending anesthetist - before and after cardiopulmonary bypass. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02655107
Study type Observational
Source University of Schleswig-Holstein
Contact
Status Completed
Phase N/A
Start date February 2015
Completion date August 2016

See also
  Status Clinical Trial Phase
Completed NCT03816514 - Noninvasive Hemoglobin Monitoring for Maintaining Hemoglobin Concentration Within the Target Range N/A
Completed NCT02722759 - Haemoglobin Measurement for Babies N/A
Completed NCT01529502 - Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This Setting Phase 2
Terminated NCT00228995 - A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia Phase 2
Terminated NCT00210795 - A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia Phase 2
Completed NCT04869319 - Electronic Triggers: Messaging After A1C EHR Alert
Recruiting NCT04189250 - Comparison of the Automatized and the Optimized Carbon Monoxid Rebreathing Protocol N/A
Completed NCT02876627 - Effect Aerobic Training on Women With Breast Cancer After Chemotherapy Phase 1
Terminated NCT00246597 - A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer Phase 3
Completed NCT05506748 - Association Between Preoperative HALP and Immediate Postoperative Outcomes